Erlocip 150mg Tablet is an anticancer medicine. Cancer is an abnormal and uncontrolled multiplication of cells within the body. It is used in the treatment of patients with advanced or metastatic non-small cell lung cancer.It is also used in advanced or metastatic non-small cell lung cancer if the previous therapy failed to stop the disease. 

Erlocip 150mg Tablet is given in combination with Gemcitabine to treat pancreas cancer at the metastatic stage. Administration of this medicine may lead to kidney and liver failure. The doctor will periodically monitor kidney and liver function. Inform the physician about any history of clotting disorders or medicines taken for clotting disorders, as the Erlocip 150mg Tablet may increase the tendency to bleed.

Patients are advised not to smoke while treated with this medicine, as smoking may decrease the amount of medicine in the blood. Wear protective clothing and sunscreen while going outside.

Advanced or metastatic non-small lung cancer (NSCLC)

Advanced or metastatic pancreatic cancer

Erlocip 150mg Tablet prevents the activity of a protein called epidermal growth factor receptor (EFGR), a protein involved in the spread and growth of cancer cells.

Always take this medicine as prescribed by the doctor. The tablet must be taken at least one hour before or two hours after taking food. Contact your doctor if you missed the dose or taken more.

Persistent or severe diarrhea

Pain in the eye, blurred vision

Sudden difficulty in breathing accompanied by cough and fever

Severe pain in your abdomen

Liver failure

Rash, worsened in sun-exposed areas

Loss of appetite, decreased weight

Infection

Headache, changes in skin sensation

Depression

Nausea

Mouth irritation

Indigestion, stomach pain, buildup of gas

Hair loss, dry skin, itching

Tiredness, fever

Abnormal liver function

Inflammation around fingernail

Acne, cracked skin

Bleeding from nose, stomach, intestines

Reduced kidney function

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Erlocip 150 mg tablet and cause undesirable side effects.

Keep out of sight and reach of children.

Store at a controlled room temperature between 15°C to 30°C.

Do not freeze.

Inform the doctor if the patient has vision problems, use of contact lenses, clotting disorders, intolerance to sugar, and medication are taken for cholesterol before starting this medication. This medication should not be taken along with the food, and it can be taken either before or after food as it increases the effectiveness of the medication. It is not recommended for individuals below 18 years of age. Inform the doctor about kidney and liver disorders, as this medication is not recommended in patients with kidney and liver disorders. Avoid making plans to have children or during pregnancy because this medicine is highly unsafe and causes harmful effects on the developing baby.